BR112012016435A2 - método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral - Google Patents

método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral

Info

Publication number
BR112012016435A2
BR112012016435A2 BR112012016435A BR112012016435A BR112012016435A2 BR 112012016435 A2 BR112012016435 A2 BR 112012016435A2 BR 112012016435 A BR112012016435 A BR 112012016435A BR 112012016435 A BR112012016435 A BR 112012016435A BR 112012016435 A2 BR112012016435 A2 BR 112012016435A2
Authority
BR
Brazil
Prior art keywords
parenteral administration
aqueous composition
sterile aqueous
hemodialysis patient
treating malnutrition
Prior art date
Application number
BR112012016435A
Other languages
English (en)
Inventor
Moore Eileen
Original Assignee
Pentec Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44226741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012016435(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pentec Health Inc filed Critical Pentec Health Inc
Publication of BR112012016435A2 publication Critical patent/BR112012016435A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
BR112012016435A 2010-01-04 2010-07-30 método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral BR112012016435A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29213910P 2010-01-04 2010-01-04
US29280610P 2010-01-06 2010-01-06
PCT/US2010/043944 WO2011081679A1 (en) 2010-01-04 2010-07-30 Nutritive compositions and methods of using same

Publications (1)

Publication Number Publication Date
BR112012016435A2 true BR112012016435A2 (pt) 2019-09-24

Family

ID=44226741

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112012016435A BR112012016435A2 (pt) 2010-01-04 2010-07-30 método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral
BRBR112012016434-1A BR112012016434A2 (pt) 2010-01-04 2010-12-15 Métodos e composição para tratar ou prevenir desnutrição em um paciente de hemodiálise

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRBR112012016434-1A BR112012016434A2 (pt) 2010-01-04 2010-12-15 Métodos e composição para tratar ou prevenir desnutrição em um paciente de hemodiálise

Country Status (13)

Country Link
US (3) US8927505B2 (pt)
EP (2) EP2521559A4 (pt)
JP (3) JP5774603B2 (pt)
KR (2) KR20120125487A (pt)
CN (2) CN102883729A (pt)
AU (2) AU2010337355A1 (pt)
BR (2) BR112012016435A2 (pt)
CA (2) CA2786375A1 (pt)
GB (2) GB2489163A (pt)
IL (1) IL220715A0 (pt)
MX (2) MX2012007704A (pt)
NZ (2) NZ601027A (pt)
WO (2) WO2011081679A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007053683A2 (en) * 2005-11-01 2007-05-10 Fresenius Medical Care Holdings, Inc. Digital data entry methods and devices
US20100137693A1 (en) * 2005-11-01 2010-06-03 Fresenius Medical Care Holdings, Inc. Methods and systems for patient care
AU2009268742C1 (en) 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
US8698741B1 (en) 2009-01-16 2014-04-15 Fresenius Medical Care Holdings, Inc. Methods and apparatus for medical device cursor control and touchpad-based navigation
US10799117B2 (en) * 2009-11-05 2020-10-13 Fresenius Medical Care Holdings, Inc. Patient treatment and monitoring systems and methods with cause inferencing
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
EP3372246B1 (en) * 2012-11-27 2021-08-11 Terumo Kabushiki Kaisha Peritoneal dialysis fluid
WO2017053328A1 (en) 2015-09-21 2017-03-30 The Board Of Trustees Of The Leland Stanford Junior University Nutritional treatment for cancer
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
WO2019118519A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy
CN114364264A (zh) * 2019-07-19 2022-04-15 飞滤森有限公司 用于癌症治疗和代谢干预疗法的组合物、方法、试剂盒和系统以及其他用途
US11278510B2 (en) 2019-09-05 2022-03-22 Baxter International Inc. Parenteral nutrition formulation with optimized amino acid and glucose content

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489097A (en) * 1976-07-28 1984-12-18 The Procter & Gamble Company Intravenous solutions with antimicrobial agent
WO1982003773A1 (en) 1981-04-27 1982-11-11 Baxter Travenol Lab Dialysis solution containing glucose,amino acids & insulin
US4491589A (en) * 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
JPS6178719A (ja) * 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
JPH0667831B2 (ja) * 1986-01-13 1994-08-31 森永乳業株式会社 肝物質合成機能障害改善用のアミノ酸組成物
US5122515A (en) 1990-06-19 1992-06-16 Smith Ross C Nutrient composition containing dipeptides and method for administering the same
US5278149A (en) 1992-01-17 1994-01-11 New England Deaconess Hospital Corporation Method of preparing total parenteral nutrition solutions
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
JP2990686B2 (ja) * 1994-11-17 1999-12-13 田辺製薬株式会社 水溶性ビタミンｂ類配合総合輸液
US6852690B1 (en) * 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
SE9703775L (sv) 1997-10-16 1999-04-17 Pharmalink Baslaekemedel Ab Framställning av sterial lösningar som innehåller glukos
US6610206B1 (en) * 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
JP2002045420A (ja) 2000-08-01 2002-02-12 Terumo Corp 血液浄化装置、血液浄化方法および透析液パッケージ
WO2002062454A1 (en) * 2001-02-07 2002-08-15 Nephros, Inc. Method and apparatus for a hemodiafiltration delivery module
EP1279400A1 (en) 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US7323206B1 (en) * 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
AU2004241840B2 (en) * 2003-05-22 2010-02-25 Otsuka Pharmaceutical Factory, Inc. Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin B1
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
JP4622311B2 (ja) * 2004-05-21 2011-02-02 味の素株式会社 末梢静脈投与用輸液
JP2007056013A (ja) 2005-07-29 2007-03-08 Ajinomoto Co Inc 透析用補充液
CA2617627C (en) 2005-08-02 2015-02-24 Baxter International Inc. Oxygen indicator for use in medical products
JP2007137836A (ja) 2005-11-21 2007-06-07 Ajinomoto Co Inc 末梢静脈栄養輸液
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
JP5316918B2 (ja) * 2006-04-24 2013-10-16 味の素株式会社 透析患者用輸液剤
CN101015501B (zh) * 2007-02-28 2012-03-07 华瑞制药有限公司 三腔袋包装的脂肪乳、氨基酸和葡萄糖注射液的组合物及其制备方法
WO2008146732A1 (ja) * 2007-05-25 2008-12-04 Ajinomoto Co., Inc. 末梢静脈投与用輸液
AU2009268742C1 (en) * 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
WO2010055963A1 (en) 2008-11-17 2010-05-20 Lee, Jin Tae Manufacturing method of acetate-free dialysate composition

Also Published As

Publication number Publication date
KR20120125487A (ko) 2012-11-15
EP2521449A1 (en) 2012-11-14
AU2010337355A1 (en) 2012-07-26
JP2013516464A (ja) 2013-05-13
EP2521559A1 (en) 2012-11-14
CN102883729A (zh) 2013-01-16
CA2786375A1 (en) 2011-07-07
GB201211991D0 (en) 2012-08-22
WO2011081660A1 (en) 2011-07-07
BR112012016434A2 (pt) 2015-09-01
GB201211987D0 (en) 2012-08-22
IL220715A0 (en) 2012-08-30
NZ601043A (en) 2014-10-31
MX2012007704A (es) 2013-01-29
AU2010337336A1 (en) 2012-07-26
NZ601027A (en) 2014-08-29
EP2521559A4 (en) 2013-05-01
CN102883603A (zh) 2013-01-16
US20120277170A1 (en) 2012-11-01
US20150080323A1 (en) 2015-03-19
MX2012007775A (es) 2013-02-21
GB2491279A (en) 2012-11-28
JP5774603B2 (ja) 2015-09-09
GB2489163A (en) 2012-09-19
KR20120104417A (ko) 2012-09-20
CA2786122A1 (en) 2011-07-11
EP2521449A4 (en) 2013-04-24
JP2015187112A (ja) 2015-10-29
WO2011081679A1 (en) 2011-07-07
US20100317602A1 (en) 2010-12-16
US8927505B2 (en) 2015-01-06
JP2013516463A (ja) 2013-05-13

Similar Documents

Publication Publication Date Title
BR112012016435A2 (pt) método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral
BR112015007061A2 (pt) composto, composição farmacêutica e método para tratar uma condição ou distúrbio dependente de apkc em um paciente
BR112015002541A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
SG10201604167XA (en) Blood treatment systems and methods
EP2569029A4 (en) SYSTEMS AND METHOD FOR IMPROVED STERILIZATION DURING A PERITONEAL DIALYSIS
BR112015010501A2 (pt) composto, composição farmacêutica, nanopartículas, método para tratar câncer em um paciente e composição liofilizada
EP2591734A4 (en) MEDICAL PUMP AND MEDICAL TREATMENT DEVICE
EP2641614A4 (en) MICRONADEL ASSEMBLY FORMULATION FOR SKIN TREATMENT
HK1243346A1 (zh) 在要求減少施用容量的患者中治療苯達莫司汀響應性狀況的方法
BR112015011271A2 (pt) cortina medicinal, sistema para o tratamento de um tecido local com a pressão reduzida, método para fabricar uma cortina medicinal, e método para o tratamento de um tecido local com a pressão reduzida
EP2746835A4 (en) MEDICAL TREATMENT DEVICE, COATING SOLUTION COMPOSITION AND METHOD OF MANUFACTURING THE MEDICAL TREATMENT DEVICE
BRPI0811845A2 (pt) Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente
HK1197159A1 (en) Pirfenidone and anti-fibrotic therapy in selected patients
EP2720623A4 (en) METHOD AND DEVICES FOR TREATING FISTLES
BR112013011968A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BR112013033078A2 (pt) partícula, composição farmacêutica, conjunto para o tratamento do câncer e método para o tratamento do câncer em um paciente
BRPI1013089A2 (pt) alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico
HK1195484A1 (zh) 治療裝置以及治療方法
PT2911716T (pt) Dispositivo de tratamento extracorporal do sangue
BR112013014546A2 (pt) dispositivo e método para administração de um dispositivo vascular
BR112014001973A2 (pt) composto e método de tratamento do câncer em um sujeito
SI2741836T1 (sl) Sestavi za obdelavo tekočin, ki vključujejo zbiralnik, in postopki obdelave tekočin
HK1170921A1 (en) Disposable aseptic safe retractile blood taking needle
EP2903632A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETES PATIENTS
HK1172569A1 (en) Chinese medicine composition for treating colds and preparation method thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.